| Product Code: ETC6743645 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Fragment Based Drug Discovery Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Fragment Based Drug Discovery Market Revenues & Volume, 2021 & 2031F |
3.3 China Fragment Based Drug Discovery Market - Industry Life Cycle |
3.4 China Fragment Based Drug Discovery Market - Porter's Five Forces |
3.5 China Fragment Based Drug Discovery Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.6 China Fragment Based Drug Discovery Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 China Fragment Based Drug Discovery Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 China Fragment Based Drug Discovery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government investments in RD initiatives related to drug discovery |
4.2.2 Rising prevalence of chronic diseases driving the demand for innovative drug development solutions |
4.2.3 Growing focus on personalized medicine and targeted therapies in China |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approval processes for drug discovery in China |
4.3.2 Limited availability of skilled professionals and expertise in fragment-based drug discovery |
4.3.3 High costs associated with research and development activities in the pharmaceutical sector |
5 China Fragment Based Drug Discovery Market Trends |
6 China Fragment Based Drug Discovery Market, By Types |
6.1 China Fragment Based Drug Discovery Market, By Component |
6.1.1 Overview and Analysis |
6.1.2 China Fragment Based Drug Discovery Market Revenues & Volume, By Component, 2021- 2031F |
6.1.3 China Fragment Based Drug Discovery Market Revenues & Volume, By Fragment Screening, 2021- 2031F |
6.1.4 China Fragment Based Drug Discovery Market Revenues & Volume, By Biophysical Techniques, 2021- 2031F |
6.1.5 China Fragment Based Drug Discovery Market Revenues & Volume, By NMR Spectroscopy, 2021- 2031F |
6.1.6 China Fragment Based Drug Discovery Market Revenues & Volume, By Differential Scanning Fluorimetry (DSF) Assay, 2021- 2031F |
6.1.7 China Fragment Based Drug Discovery Market Revenues & Volume, By Fluorescence Polarization, 2021- 2031F |
6.1.8 China Fragment Based Drug Discovery Market Revenues & Volume, By Isothermal Titration Calorimetry, 2021- 2031F |
6.1.9 China Fragment Based Drug Discovery Market Revenues & Volume, By Surface Plasmon Resonance (SPR), 2021- 2031F |
6.1.10 China Fragment Based Drug Discovery Market Revenues & Volume, By Surface Plasmon Resonance (SPR), 2021- 2031F |
6.2 China Fragment Based Drug Discovery Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Fragment Based Drug Discovery Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.3 China Fragment Based Drug Discovery Market Revenues & Volume, By Central Nervous System (CNS) Disorders, 2021- 2031F |
6.2.4 China Fragment Based Drug Discovery Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.5 China Fragment Based Drug Discovery Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.2.6 China Fragment Based Drug Discovery Market Revenues & Volume, By Metabolic Disorders, 2021- 2031F |
6.2.7 China Fragment Based Drug Discovery Market Revenues & Volume, By Inflammation & Autoimmune Diseases, 2021- 2031F |
6.3 China Fragment Based Drug Discovery Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 China Fragment Based Drug Discovery Market Revenues & Volume, By Academic & Research Institutions, 2021- 2031F |
6.3.3 China Fragment Based Drug Discovery Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.3.4 China Fragment Based Drug Discovery Market Revenues & Volume, By Contract Research Organizations (CROs), 2021- 2031F |
7 China Fragment Based Drug Discovery Market Import-Export Trade Statistics |
7.1 China Fragment Based Drug Discovery Market Export to Major Countries |
7.2 China Fragment Based Drug Discovery Market Imports from Major Countries |
8 China Fragment Based Drug Discovery Market Key Performance Indicators |
8.1 Number of research collaborations between academic institutions and pharmaceutical companies in China |
8.2 Percentage increase in the number of patents related to fragment-based drug discovery filed by Chinese companies |
8.3 Adoption rate of innovative technologies and methodologies in the drug discovery process in China |
9 China Fragment Based Drug Discovery Market - Opportunity Assessment |
9.1 China Fragment Based Drug Discovery Market Opportunity Assessment, By Component, 2021 & 2031F |
9.2 China Fragment Based Drug Discovery Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 China Fragment Based Drug Discovery Market Opportunity Assessment, By End User, 2021 & 2031F |
10 China Fragment Based Drug Discovery Market - Competitive Landscape |
10.1 China Fragment Based Drug Discovery Market Revenue Share, By Companies, 2024 |
10.2 China Fragment Based Drug Discovery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here